Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403312 · ClinicalTrials.gov registry record · NA
Increasing Physical Activity as Part of a Smoking Cessation Program
A NA study of Smoking Cessation, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 2
- Study locations
NCT00403312: Completed NA study of Smoking Cessation, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00403312 is a NA study of Smoking Cessation that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 400 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (15% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00403312, a NA study of Smoking Cessation, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 2
- Study locations
Study Summary
Cigarette smoking is the most common risk factor for lung cancer, and it increases the risk of developing other cancers, chronic lung disease, and heart disease. A smoking cessation program that incorporates physical activity may be beneficial in improving long-term smoking cessation rates. This study will evaluate the effectiveness of a community-based physical activity program, in combination with nicotine replacement therapy and a behavioral smoking cessation program, at improving cessation rates among sedentary smokers.
Conditions Studied
Interventions
- BEHAVIORAL Physical Activity
- DRUG Nicotine Patch
- BEHAVIORAL Smoking Cessation Behavioral Program
Study Locations (2)
Tennessee
- University of Memphis Center for Community Health - Memphis
- Department of Preventive Medicine, University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2003-01 |
| Phase | NA |
What the finished NCT00403312 record still lists
NCT00403312 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which Physical Activity is the first listed.
NCT00403312 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00403312 about?
NCT00403312 is a clinical study titled "Increasing Physical Activity as Part of a Smoking Cessation Program". Cigarette smoking is the most common risk factor for lung cancer, and it increases the risk of developing other cancers, chronic lung disease, and heart disease. A smoking cessation program that incorporates physical activity may be beneficial in improving long-term smoking cessation rates. This stu...
What is the current status of trial NCT00403312?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2003-01.
What conditions does trial NCT00403312 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT00403312?
The interventions under investigation include: Physical Activity (BEHAVIORAL), Nicotine Patch (DRUG), Smoking Cessation Behavioral Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00403312?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00403312 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00403312's enrollment target sits among peer trials
400 68th of 188 higher than 120 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia